Liver Metastases
Cetuximab enables liver metastasis surgery in colorectal cancer
April 22, 2013Combining cetuximab (Erbitux) with standard therapy improved the resectability of previously inoperable liver metastases of colorectal cancer.
Everolimus combination improved progression-free survival in neuroendocrine tumors
December 14, 2011Progression-free survival improved in patients with advanced neuroendocrine tumors when everolimus rather than placebo was used in combination with octreotide long-acting repeatable.
Y-90 radioembolization extends life in liver cancer
April 12, 2011Higher doses of yttrium-90 (Y-90) than previously used in intra-arterial radioembolization to treat persons with liver tumors provide results when chemotherapies have failed.
Protein may predict cancer metastasis
February 15, 2011The presence of high levels of a particular protein in tumors drives metastasis, providing a valuable biomarker for predicting the spread of cancer.
Case Study: Downstaging liver metastases in colorectal cancer
January 22, 2010A 35-year-old woman presents with a one-day history of lower-right abdominal pain, setting the stage for chemotherapy for metastatic colorectal cancer
Sign Up for Free e-newsletters
ONA Articles
- Factoring in Breast Density Improves Long-Term Risk Models for Breast Cancer
- Physical Inactivity Linked With Increased Risk of Hodgkin, Non-Hodgkin Lymphoma
- Challenges for Young Adult Couples Facing a Cancer Diagnosis
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Progression-Free Survival Extended With PANEX Protocol in R/R Multiple Myeloma
- Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Long-term Carfilzomib May Be Safe, Effective In Relapsed Multiple Myeloma
- Palliative Sedation a Valid Option for Refractory Symptoms in End-stage Cancer
- Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors
- FDA Approves Fostamatinib for ITP After Insufficient Response to Previous Treatment
- Elderly Patients Are Underrepresented in Trials For Soft Tissue Sarcoma
- Combination Effective as First-Line Therapy in Advanced ER-Positive HER2-Negative Breast Cancer
- In Older Women With Breast Cancer QoL May Predict 10-Year Mortality
- Screening Colonoscopy Improves CRC-Related Mortality in Veterans
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |